Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Priming”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05846516
What this trial is testing

Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Boehringer Ingelheim 59
Large-scale testing (Phase 3)Study completedNCT02094833
What this trial is testing

DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 310
Early research (Phase 1)Study completedNCT00955006
What this trial is testing

Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 17
Testing effectiveness (Phase 2)Study completedNCT00375128
What this trial is testing

Sporozoite Challenge of Polyprotein Vaccinees

Who this might be right for
Malaria, FalciparumMalaria
European Vaccine Initiative 26
Testing effectiveness (Phase 2)Ended earlyNCT03866187
What this trial is testing

Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection

Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 236
Testing effectiveness (Phase 2)Study completedNCT00943202
What this trial is testing

Sanofi Pasteur, TIV + H1N1, Pediatric Population

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 531
Not applicableLooking for participantsNCT07393412
What this trial is testing

Identifying Risk Factors and Predicting Future Health Outcomes for Korean Patients With Heart and Blood Vessel Diseases: A Long-term Follow-up Study

Who this might be right for
Cardiovascular Diseases (CVD)Cerebro Vascular Disease
Samsung Medical Center 800,000
Not applicableUnknownNCT05735405
What this trial is testing

Aerobic Exercise and Cognitive Training in Patients With Stroke

Who this might be right for
Ischemic StrokeHemorrhagic Stroke
Fondazione Don Carlo Gnocchi ETS 30
Early research (Phase 1)Study completedNCT01086657
What this trial is testing

An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...

Who this might be right for
Influenza A Virus, H5N1 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 64
Early research (Phase 1)Study completedNCT06070051
What this trial is testing

Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy

Who this might be right for
Chronic Hepatitis B
Virion Therapeutics 35
Not applicableUnknownNCT05937451
What this trial is testing

Prediction and Management of Acute Kidney Injury With Explainable Artificial Intelligence

Who this might be right for
Acute Kidney Injury
Seoul National University Hospital 1,438
Not applicableStudy completedNCT01479751
What this trial is testing

Comparison of Methods to Facilitate Rapid Sequence Intubation

Who this might be right for
Intubating Condition
Seoul National University Bundang Hospital 110
Early research (Phase 1)WithdrawnNCT02993991
What this trial is testing

Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral Cavity

Who this might be right for
Squamous Cell Carcinoma, Head And NeckSquamous Cell Carcinoma MouthResectable Squamous Cell Carcinoma of Oral Cavity
University Health Network, Toronto
Not applicableUnknownNCT05067829
What this trial is testing

Rapid Sequence Intubation With Rocuronium in Elderly Patients

Who this might be right for
Rapid Sequence InductionRapid Sequence IntubationRocuronium
Ankara City Hospital Bilkent 75
Not applicableStudy completedNCT03060824
What this trial is testing

Changes in Plasma Osmolality Related to the Use of Cardiopulmonary Bypass With Hyperosmolar Prime.

Who this might be right for
Cardiopulmonary Bypass
Umeå University 30
Large-scale testing (Phase 3)Study completedNCT05223361
What this trial is testing

Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery

Who this might be right for
Heart Valve Diseases
Rajaie Cardiovascular Medical and Research Center 120
Testing effectiveness (Phase 2)Looking for participantsNCT02889003
What this trial is testing

Second STOP After Pioglitazone Priming in CML Patients

Who this might be right for
Chronic Myeloid Leukemia (CML)
Versailles Hospital 26
Testing effectiveness (Phase 2)Study completedNCT04607850
What this trial is testing

Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions

Who this might be right for
HPV InfectionCIN1
Barinthus Biotherapeutics 108
Early research (Phase 1)Study completedNCT04776317
What this trial is testing

Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 81
Large-scale testing (Phase 3)Study completedNCT01379937
What this trial is testing

Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children

Who this might be right for
Influenza
GlaxoSmithKline 520
Next Page